Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Follis

Showing results (131-140 of 201) with videos related to

Pageof 21
Sort By:
The Journal of Biological Chemistry|June 20, 2019
Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiologyCarlos G Vanoye, Masayoshi Sakakura, Rose M Follis, et al.
Preventive Medicine|December 14, 2023
Allostatic load and risk of invasive breast cancer among postmenopausal women in the U.SFengge Wang, Meghan B Skiba, Shawna Follis, et al.
Molecular Cancer Therapeutics|September 19, 2007
Improved low molecular weight Myc-Max inhibitorsHuabo Wang, Dalia I Hammoudeh, Ariele Viacava Follis, et al.
Journal of Virology|March 14, 1998
Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivityR A LaCasse, K E Follis, T Moudgil, et al.
Science (New York, N.Y.)|November 17, 1995
Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenineC C Tsai, K E Follis, A Sabo, et al.
Marine Environmental Research|October 9, 2018
Hierarchical structuring of genetic variation at differing geographic scales in the cultivated sugar kelp Saccharina latissimaKaren M Mooney, Gemma E Beatty, Björn Elsäßer, et al.
Journal of Acquired Immune Deficiency Syndromes|October 1, 1993
Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virusC C Tsai, K E Follis, R F Grant, et al.
The Journal of Infectious Diseases|February 1, 1994
Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaquesC C Tsai, K E Follis, A Sabo, et al.
Journal of Medicinal Chemistry|February 14, 2009
Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore modelGabriela Mustata, Ariele Viacava Follis, Dalia I Hammoudeh, et al.
Journal of Virology|April 29, 1998
Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatmentC C Tsai, P Emau, K E Follis, et al.
Pageof 21

Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
The Journal of Biological Chemistry|June 20, 2019
Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiologyCarlos G Vanoye, Masayoshi Sakakura, Rose M Follis, et al.
Preventive Medicine|December 14, 2023
Allostatic load and risk of invasive breast cancer among postmenopausal women in the U.SFengge Wang, Meghan B Skiba, Shawna Follis, et al.
Molecular Cancer Therapeutics|September 19, 2007
Improved low molecular weight Myc-Max inhibitorsHuabo Wang, Dalia I Hammoudeh, Ariele Viacava Follis, et al.
Journal of Virology|March 14, 1998
Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivityR A LaCasse, K E Follis, T Moudgil, et al.
Science (New York, N.Y.)|November 17, 1995
Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenineC C Tsai, K E Follis, A Sabo, et al.
Marine Environmental Research|October 9, 2018
Hierarchical structuring of genetic variation at differing geographic scales in the cultivated sugar kelp Saccharina latissimaKaren M Mooney, Gemma E Beatty, Björn Elsäßer, et al.
Journal of Acquired Immune Deficiency Syndromes|October 1, 1993
Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virusC C Tsai, K E Follis, R F Grant, et al.
The Journal of Infectious Diseases|February 1, 1994
Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaquesC C Tsai, K E Follis, A Sabo, et al.
Journal of Medicinal Chemistry|February 14, 2009
Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore modelGabriela Mustata, Ariele Viacava Follis, Dalia I Hammoudeh, et al.
Journal of Virology|April 29, 1998
Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatmentC C Tsai, P Emau, K E Follis, et al.
Pageof 21